Literature DB >> 17071589

A role for tyrosinase-related protein 1 in 4-tert-butylphenol-induced toxicity in melanocytes: Implications for vitiligo.

Prashiela Manga1, David Sheyn, Fan Yang, Rangaprasad Sarangarajan, Raymond E Boissy.   

Abstract

Vitiligo presents with depigmented cutaneous lesions following localized melanocyte death. Multiple factors contribute to cell death, including genetically determined susceptibility to trauma, and environmental factors, such as exposure to 4-tert-butylphenol (4-TBP). We demonstrate that 4-TBP induces oxidative stress that is more readily overcome by melanocytes from normally pigmented individuals than from two individuals with vitiligo. The antioxidant catalase selectively and significantly reduced death of melanocytes derived from two individuals with vitiligo, indicating a role for oxidative stress in vitiligo pathogenesis. In normal melanocytes, oxidative stress results in reduced expression of microphthalmia-associated transcription factor (MITF). Melanocyte-stimulating hormone-induced expression of MITF protein caused increased sensitivity to 4-TBP, whereas sensitivity of melanomas correlated with MITF expression. MITF stimulates melanin synthesis by up-regulating expression of melanogenic enzymes such as tyrosinase-related protein-1 (Tyrp1). Although melanin content per se did not affect sensitivity to 4-TBP, expression of Tyrp1 significantly increased sensitivity. Melanocytes and melanomas that express functional Tyrp1 were significantly more sensitive to 4-TBP than Tyrp1-null cells. Thus, normal melanocytes respond to 4-TBP by reducing expression of MITF and Tyrp1. We hypothesize that melanocytes in vitiligo demonstrate reduced ability to withstand oxidative stress due, partly, to a disruption in MITF regulation of Tyrp1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17071589      PMCID: PMC1780195          DOI: 10.2353/ajpath.2006.050769

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  49 in total

1.  PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum.

Authors:  I C Le Poole; R E Boissy; R Sarangarajan; J Chen; J J Forristal; P Sheth; W Westerhof; G Babcock; P K Das; C B Saelinger
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-05       Impact factor: 2.416

2.  The cytotoxicity and apoptosis induced by 4-tertiary butylphenol in human melanocytes are independent of tyrosinase activity.

Authors:  F Yang; R Sarangarajan; I C Le Poole; E E Medrano; R E Boissy
Journal:  J Invest Dermatol       Date:  2000-01       Impact factor: 8.551

3.  Effects of commonly used mitogens on the cytotoxicity of 4-tertiary butylphenol to human melanocytes.

Authors:  F Yang; Z Abdel-Malek; R E Boissy
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Nov-Dec       Impact factor: 2.416

Review 4.  In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase.

Authors:  K U Schallreuter; J Moore; J M Wood; W D Beazley; D C Gaze; D J Tobin; H S Marshall; A Panske; E Panzig; N A Hibberts
Journal:  J Investig Dermatol Symp Proc       Date:  1999-09

5.  Tyrosinase action on monophenols: evidence for direct enzymatic release of o-diphenol.

Authors:  J N Rodríguez-López; L G Fenoll; M J Peñalver; P A García-Ruiz; R Varón; F Martínez-Ortíz; F García-Cánovas; J Tudela
Journal:  Biochim Biophys Acta       Date:  2001-08-13

6.  Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9.

Authors:  W Xu; L Gong; M M Haddad; O Bischof; J Campisi; E T Yeh; E E Medrano
Journal:  Exp Cell Res       Date:  2000-03-15       Impact factor: 3.905

7.  Tyrosinase-mediated formation of a reactive quinone from the depigmenting agents, 4-tert-butylphenol and 4-tert-butylcatechol.

Authors:  K Thörneby-Andersson; O Sterner; C Hansson
Journal:  Pigment Cell Res       Date:  2000-02

8.  Epidermal H(2)O(2) accumulation alters tetrahydrobiopterin (6BH4) recycling in vitiligo: identification of a general mechanism in regulation of all 6BH4-dependent processes?

Authors:  K U Schallreuter; J Moore; J M Wood; W D Beazley; E M Peters; L K Marles; S C Behrens-Williams; R Dummer; N Blau; B Thöny
Journal:  J Invest Dermatol       Date:  2001-01       Impact factor: 8.551

9.  Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo.

Authors:  K Jimbow; H Chen; J S Park; P D Thomas
Journal:  Br J Dermatol       Date:  2001-01       Impact factor: 9.302

10.  Inhibition of melanogenesis in response to oxidative stress: transient downregulation of melanocyte differentiation markers and possible involvement of microphthalmia transcription factor.

Authors:  C Jiménez-Cervantes; M Martínez-Esparza; C Pérez; N Daum; F Solano; J C García-Borrón
Journal:  J Cell Sci       Date:  2001-06       Impact factor: 5.285

View more
  18 in total

1.  Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo.

Authors:  R Dey-Rao; A A Sinha
Journal:  Genes Immun       Date:  2015-11-12       Impact factor: 2.676

2.  Update on the genetics characterization of vitiligo.

Authors:  Hani A Al-Shobaili
Journal:  Int J Health Sci (Qassim)       Date:  2011-07

3.  Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress.

Authors:  Jeffrey A Mosenson; Kelsey Flood; Jared Klarquist; Jonathan M Eby; Amy Koshoffer; Raymond E Boissy; Andreas Overbeck; Rebecca C Tung; I Caroline Le Poole
Journal:  Pigment Cell Melanoma Res       Date:  2014-01-13       Impact factor: 4.693

Review 4.  [Induction of occupational leucoderma and vitiligo. Can butylated hydroxytoluene induce vitiligo similarly to p-tert-butylphenol?].

Authors:  H C Broding; C Monsé; T Brüning; M Fartasch
Journal:  Hautarzt       Date:  2011-03       Impact factor: 0.751

5.  Topical application of bleaching phenols; in-vivo studies and mechanism of action relevant to melanoma treatment.

Authors:  Vidhya Hariharan; Timothy Toole; Jared Klarquist; Jeffrey Mosenson; B Jack Longley; I Caroline Le Poole
Journal:  Melanoma Res       Date:  2011-04       Impact factor: 3.599

6.  The nuclear factor (erythroid-derived 2)-like 2 (NRF2) antioxidant response promotes melanocyte viability and reduces toxicity of the vitiligo-inducing phenol monobenzone.

Authors:  Omotayo A Arowojolu; Seth J Orlow; Nada Elbuluk; Prashiela Manga
Journal:  Exp Dermatol       Date:  2017-07       Impact factor: 3.960

Review 7.  Tyrosinase related protein 1 (TYRP1/gp75) in human cutaneous melanoma.

Authors:  Ghanem Ghanem; Journé Fabrice
Journal:  Mol Oncol       Date:  2011-02-03       Impact factor: 6.603

8.  Increased level of serum Homocysteine in vitiligo.

Authors:  Suman Singh; Usha Singh; Shyam Sunder Pandey
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

9.  Isolation and characterization of 4-tert-butylphenol-utilizing Sphingobium fuliginis strains from Phragmites australis rhizosphere sediment.

Authors:  Tadashi Toyama; Naonori Momotani; Yuka Ogata; Yuji Miyamori; Daisuke Inoue; Kazunari Sei; Kazuhiro Mori; Shintaro Kikuchi; Michihiko Ike
Journal:  Appl Environ Microbiol       Date:  2010-08-27       Impact factor: 4.792

10.  Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaff.

Authors:  Raymond E Boissy; Richard A Spritz
Journal:  Exp Dermatol       Date:  2009-03-06       Impact factor: 3.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.